We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
2276
Immunovant
IMVT
$8.64B
$129K ﹤0.01%
12,245
+2,885
+31% +$40.3K
OLMA icon
2277
Olema Pharmaceuticals
OLMA
$920M
$129K ﹤0.01%
4,614
+513
+13% +$14.6K
LIND icon
2278
Lindblad Expeditions
LIND
$2.26B
$129K ﹤0.01%
8,059
ORIC icon
2279
Oric Pharmaceuticals
ORIC
$1.42B
$129K ﹤0.01%
7,292
+688
+10% +$15.1K
CGEM icon
2280
Cullinan Oncology
CGEM
$1.26B
$129K ﹤0.01%
5,002
+545
+12% +$16.8K
BPOP icon
2281
Popular Inc
BPOP
$11.3B
$129K ﹤0.01%
1,713
+34
+2% +$2.6K
CURI icon
2282
CuriosityStream
CURI
$237M
$129K ﹤0.01%
+9,424
New +$122K
CPRX
2283
DELISTED
Catalyst Pharmaceutical
CPRX
$128K ﹤0.01%
22,298
-8,020
-26% -$41.4K
UAVS icon
2284
AgEagle Aerial Systems
UAVS
$62.7M
$128K ﹤0.01%
+24
New +$132K
MSGS icon
2285
Madison Square Garden
MSGS
$9.94B
$128K ﹤0.01%
741
+361
+95% +$65.3K
BW icon
2286
Babcock & Wilcox
BW
$1.39B
$128K ﹤0.01%
+16,211
New +$134K
ATRO icon
2287
Astronics
ATRO
$4.57B
$128K ﹤0.01%
8,753
VIRX
2288
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$128K ﹤0.01%
+11,260
New +$113K
CLW icon
2289
Clearwater Paper
CLW
$354M
$128K ﹤0.01%
4,403
ALTO icon
2290
Alto Ingredients
ALTO
$326M
$127K ﹤0.01%
+20,852
New +$121K
HT
2291
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$127K ﹤0.01%
11,810
+3,299
+39% +$36.4K
TMX
2292
DELISTED
Terminix Global Holdings, Inc.
TMX
$127K ﹤0.01%
2,660
-18
-0.7% -$884
NDLS icon
2293
Noodles & Co
NDLS
$100M
$127K ﹤0.01%
1,269
+288
+29% +$26.8K
DMRC icon
2294
Digimarc Corp
DMRC
$158M
$126K ﹤0.01%
3,771
APEI icon
2295
American Public Education
APEI
$828M
$126K ﹤0.01%
4,454
+743
+20% +$22.4K
NAGE
2296
Niagen Bioscience
NAGE
$241M
$126K ﹤0.01%
12,770
+1,604
+14% +$14K
CONN
2297
DELISTED
Conn's Inc.
CONN
$126K ﹤0.01%
+4,929
New +$114K
GCMG icon
2298
GCM Grosvenor
GCMG
$2.85B
$126K ﹤0.01%
+12,062
New +$143K
PLTK icon
2299
Playtika
PLTK
$961M
$126K ﹤0.01%
5,271
+1,811
+52% +$47.4K
TMCI icon
2300
Treace Medical Concepts
TMCI
$293M
$126K ﹤0.01%
+4,015
New +$128K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.